References
1. Patriarca F, Skert C, Sperotto A, Damiani D, Cerno M, Geromin A, Zaja
F, Stocchi R, Prosdocimo S, Fili C, et al. Incidence, outcome, and risk
factors of late-onset noninfectious pulmonary complications after
unrelated donor stem cell transplantation. Bone Marrow Transplant
2004;33:751-758.
2. Ralph DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R, Thomas
ED. Rapidly progressive air-flow obstruction in marrow transplant
recipients. Possible association between obliterative bronchiolitis and
chronic graft-versus-host disease. Am Rev Respir Dis 1984;129:641-644.
3. Santo Tomas LH, Loberiza FR, Jr., Klein JP, Layde PM, Lipchik RJ,
Rizzo JD, Bredeson CN, Horowitz MM. Risk factors for bronchiolitis
obliterans in allogeneic hematopoietic stem-cell transplantation for
leukemia. Chest 2005;128:153-161.
4. Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A.
Long-term pulmonary function abnormalities and survival after allogeneic
marrow transplantation. Bone Marrow Transplant 2004;33:509-517.
5. Kwok WC, Liang BM, Lui MMS, Tam TCC, Sim JPY, Tse EWC, Leung AYH,
Kwong YL, Lie AKW, Ip MSM, et al. Rapid versus gradual lung function
decline in bronchiolitis obliterans syndrome after haematopoietic stem
cell transplantation is associated with survival outcome. Respirology
2019;24:459-466.
6. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C.
Pulmonary complications after bone marrow transplantation in children:
twenty-four years of experience in a single pediatric center. Pediatr
Pulmonol 2000;30:393-401.
7. Walther S, Rettinger E, Maurer HM, Pommerening H, Jarisch A, Sorensen
J, Schubert R, Berres M, Bader P, Zielen S, et al. Long-term pulmonary
function testing in pediatric bronchiolitis obliterans syndrome after
hematopoietic stem cell transplantation. Pediatr Pulmonol 2020.
8. Ditschkowski M, Elmaagacli AH, Koldehoff M, Gromke T, Trenschel R,
Beelen DW. Bronchiolitis obliterans after allogeneic hematopoietic SCT:
further insight–new perspectives? Bone Marrow Transplant
2013;48:1224-1229.
9. Nakaseko C, Ozawa S, Sakaida E, Sakai M, Kanda Y, Oshima K, Kurokawa
M, Takahashi S, Ooi J, Shimizu T, et al. Incidence, risk factors and
outcomes of bronchiolitis obliterans after allogeneic stem cell
transplantation. Int J Hematol 2011;93:375-382.
10. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory
GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an
update of the diagnostic criteria. J Heart Lung Transplant
2002;21:297-310.
11. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW,
Palmer J, Weisdorf D, Treister NS, Cheng GS, et al. National Institutes
of Health Consensus Development Project on Criteria for Clinical Trials
in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging
Working Group report. Biol Blood Marrow Transplant 2015;21:389-401.e381.
12. Lama VN, Murray S, Lonigro RJ, Toews GB, Chang A, Lau C, Flint A,
Chan KM, Martinez FJ. Course of FEV(1) after onset of bronchiolitis
obliterans syndrome in lung transplant recipients. Am J Respir Crit Care
Med 2007;175:1192-1198.
13. Moran TJ, Hellstrom HR. Bronchiolitis obliterans: an experimental
study of the pathogenesis and the use of cortisone in modification of
the lesions. AMA Arch Pathol 1958;66:691-707.
14. Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr
Opin Pediatr 2008;20:272-278.
15. Zhang L, Silva FA. [Bronchiolitis obliterans in children]. J
Pediatr (Rio J) 2000;76:185-192.
16. Teper A, Fischer GB, Jones MH. [Respiratory sequelae of viral
diseases: from diagnosis to treatment]. J Pediatr (Rio J) 2002;78
Suppl 2:S187-194.
17. Tomikawa SO, Adde FV, da Silva Filho LV, Leone C, Rodrigues JC.
Follow-up on pediatric patients with bronchiolitis obliterans treated
with corticosteroid pulse therapy. Orphanet J Rare Dis 2014;9:128.
18. Williams KM, Cheng GS, Pusic I, Jagasia M, Burns L, Ho VT, Pidala J,
Palmer J, Johnston L, Mayer S, et al. Fluticasone, Azithromycin, and
Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome
after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant
2016;22:710-716.
19. Cheng GS, Storer B, Chien JW, Jagasia M, Hubbard JJ, Burns L, Ho VT,
Pidala J, Palmer J, Johnston L, et al. Lung Function Trajectory in
Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell
Transplant. Ann Am Thorac Soc 2016;13:1932-1939.
20. Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis
obliterans after allogeneic hematopoietic stem cell transplantation.
Jama 2009;302:306-314.
21. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ,
Martin P, Chien J, Przepiorka D, Couriel D, et al. National Institutes
of Health consensus development project on criteria for clinical trials
in chronic graft-versus-host disease: I. Diagnosis and staging working
group report. Biol Blood Marrow Transplant 2005;11:945-956.
22. Walsh BK, Smallwood CD. Pediatric Oxygen Therapy: A Review and
Update. Respir Care 2017;62:645-661.
23. Barker AF, Bergeron A, Rom WN, Hertz MI. Obliterative bronchiolitis.
N Engl J Med 2014;370:1820-1828.
24. Chambers DC. Bronchiolitis obliterans syndrome ’endotypes’ in
haematopoietic stem cell transplantation. Respirology 2019;24:408-409.
25. Fakhro M, Ingemansson R, Algotsson L, Lindstedt S. Impact of Forced
Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3,
6, and 12 Months and Annually on Survival and Occurrence of
Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation. Ann
Transplant 2017;22:532-540.
26. Belperio JA, Weigt SS, Fishbein MC, Lynch JP, 3rd. Chronic lung
allograft rejection: mechanisms and therapy. Proc Am Thorac Soc
2009;6:108-121.
27. Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Saggar R, Lynch
JP, Belperio JA. Chronic allograft rejection: epidemiology, diagnosis,
pathogenesis, and treatment. Semin Respir Crit Care Med 2010;31:189-207.
28. Mathai SK, Schwartz DA, Warg LA. Genetic susceptibility and
pulmonary fibrosis. Curr Opin Pulm Med 2014;20:429-435.
29. Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry:
interpretation and practical applications. Chest 2014;146:841-847.
30. van Noord JA, Clement J, Cauberghs M, Mertens I, Van de Woestijne
KP, Demedts M. Total respiratory resistance and reactance in patients
with diffuse interstitial lung disease. Eur Respir J 1989;2:846-852.
31. Van Noord JA, Clement J, Van de Woestijne KP, Demedts M. Total
respiratory resistance and reactance in patients with asthma, chronic
bronchitis, and emphysema. Am Rev Respir Dis 1991;143:922-927.
32. Lee E, Yoon J, Cho HJ, Hong SJ, Yu J. Respiratory reactance in
children aged three to five years with postinfectious bronchiolitis
obliterans is higher than in those with asthma. Acta Paediatr
2017;106:81-86.
33. Kim HG, Shin HJ, Kim YH, Sohn MH, Lyu CJ, Kim MJ, Kim KW, Lee MJ.
Quantitative computed tomography assessment of graft-versus-host
disease-related bronchiolitis obliterans in children: A pilot
feasibility study. Eur Radiol 2015;25:2931-2936.
34. Lucaya J, Garcia-Pena P, Herrera L, Enriquez G, Piqueras J.
Expiratory chest CT in children. AJR Am J Roentgenol 2000;174:235-241.